These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7681164)

  • 1. Databases.
    Furman S
    Pacing Clin Electrophysiol; 1993 Jan; 16(1 Pt 1):1-2. PubMed ID: 7681164
    [No Abstract]   [Full Text] [Related]  

  • 2. High quality performance of pacemakers and implantable defibrillators.
    Levine PA; Stanton MS; Sims JJ
    Pacing Clin Electrophysiol; 2002 Dec; 25(12):1667-9. PubMed ID: 12520665
    [No Abstract]   [Full Text] [Related]  

  • 3. User based pacemaker and ICD registries.
    Furman S
    Pacing Clin Electrophysiol; 2002 Dec; 25(12):1665-6. PubMed ID: 12520664
    [No Abstract]   [Full Text] [Related]  

  • 4. Performance of implantable cardiac rhythm management devices.
    Song SL
    Pacing Clin Electrophysiol; 1994 Apr; 17(4 Pt 1):692-708. PubMed ID: 7516555
    [No Abstract]   [Full Text] [Related]  

  • 5. The Bilitch report.
    Furman S
    Pacing Clin Electrophysiol; 1994 Apr; 17(4 Pt 1):690-1. PubMed ID: 7516554
    [No Abstract]   [Full Text] [Related]  

  • 6. Postmortem analysis and retrieval of implantable pacemakers and defibrillators.
    Kirkpatrick JN; Burke MC; Knight BP
    N Engl J Med; 2006 Apr; 354(15):1649-50. PubMed ID: 16611964
    [No Abstract]   [Full Text] [Related]  

  • 7. Life-threatening malfunction of implantable cardiac devices.
    Myerburg RJ; Feigal DW; Lindsay BD
    N Engl J Med; 2006 Jun; 354(22):2309-11. PubMed ID: 16702187
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiarrhythmic device advisories and recalls: managing an increasingly vulnerable process.
    Saksena S
    Pacing Clin Electrophysiol; 1999 Jun; 22(6 Pt 1):950-2. PubMed ID: 10392395
    [No Abstract]   [Full Text] [Related]  

  • 9. Health care policy and regulatory implications on medical device innovations: a cardiac rhythm medical device industry perspective.
    Sharma A; Blank A; Patel P; Stein K
    J Interv Card Electrophysiol; 2013 Mar; 36(2):107-17. PubMed ID: 23474980
    [No Abstract]   [Full Text] [Related]  

  • 10. The Food and Drug Administration's regulation of risk disclosure for implantable cardioverter defibrillators: has technology outpaced the Agency's regulatory framework?
    Basile EM; Lorell BH
    Food Drug Law J; 2006; 61(2):251-72. PubMed ID: 16903031
    [No Abstract]   [Full Text] [Related]  

  • 11. Postmarketing surveillance of medical devices--filling in the gaps.
    Resnic FS; Normand SL
    N Engl J Med; 2012 Mar; 366(10):875-7. PubMed ID: 22332950
    [No Abstract]   [Full Text] [Related]  

  • 12. Recalls and safety alerts involving pacemakers and implantable cardioverter-defibrillator generators.
    Maisel WH; Sweeney MO; Stevenson WG; Ellison KE; Epstein LM
    JAMA; 2001 Aug; 286(7):793-9. PubMed ID: 11497532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Food and Drug Administration perspective: Magnetic resonance imaging of pacemaker and implantable cardioverter-defibrillator patients.
    Faris OP; Shein M
    Circulation; 2006 Sep; 114(12):1232-3. PubMed ID: 16982951
    [No Abstract]   [Full Text] [Related]  

  • 14. The Fidelis recall: how much pressure can the ICD world bear?
    Cannom DS; Fisher J
    Pacing Clin Electrophysiol; 2008 Oct; 31(10):1233-5. PubMed ID: 18811800
    [No Abstract]   [Full Text] [Related]  

  • 15. Government viewpoint: U.S. Food & Drug Administration: Pacemakers, ICDs and MRI.
    Faris OP; Shein MJ
    Pacing Clin Electrophysiol; 2005 Apr; 28(4):268-9. PubMed ID: 15826256
    [No Abstract]   [Full Text] [Related]  

  • 16. European Heart Rhythm Association Guidance Document on cardiac rhythm management product performance.
    Auricchio A; Gropp M; Ludgate S; Vardas P; Brugada J; Priori SG;
    Europace; 2006 May; 8(5):313-22. PubMed ID: 16635986
    [No Abstract]   [Full Text] [Related]  

  • 17. Pacemaker malfunction risks within the electromagnetically rich hospital environment.
    Kakouros N; Kakouros SN
    Hellenic J Cardiol; 2018; 59(4):247-248. PubMed ID: 29154816
    [No Abstract]   [Full Text] [Related]  

  • 18. Why the FDA can't protect the public.
    Lenzer J; Brownlee S
    BMJ; 2010 Nov; 341():c4753. PubMed ID: 21045048
    [No Abstract]   [Full Text] [Related]  

  • 19. Value of unique device identification in the digital health infrastructure.
    Wilson NA; Drozda J
    JAMA; 2013 May; 309(20):2107-8. PubMed ID: 23695480
    [No Abstract]   [Full Text] [Related]  

  • 20. Report of the Policy Conference of NASPE on device/lead performance and the development of a postmarket surveillance database. The Writing Committee.
    Maloney JD; Hayes DL; Timmis GC
    Pacing Clin Electrophysiol; 1993 Oct; 16(10):1945-52. PubMed ID: 7694239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.